BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 17480117)

  • 21. Factors associated with pandemic influenza A/H1N1 vaccine coverage in a French cohort of HIV-infected patients.
    Cotte L; Voirin N; Richard C; Brochier C; Schlienger I; Lack P; Lina B; Vanhems P; Zoulim F
    Vaccine; 2011 Aug; 29(34):5638-44. PubMed ID: 21699948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - results from thirteen consecutive cross-sectional surveys.
    Walter D; Böhmer MM; Heiden Ma; Reiter S; Krause G; Wichmann O
    Vaccine; 2011 May; 29(23):4008-12. PubMed ID: 21463683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revisiting the influenza vaccine.
    Foster SL; Nevin-Woods CR
    J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S2-4. PubMed ID: 22086891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009.
    Tuppin P; Samson S; Weill A; Ricordeau P; Allemand H
    Vaccine; 2011 Jun; 29(28):4632-7. PubMed ID: 21550376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical immune and vaccination thresholds for determining multiple influenza epidemic waves.
    Matrajt L; Longini IM
    Epidemics; 2012 Mar; 4(1):22-32. PubMed ID: 22325011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of influenza infection with low vaccine effectiveness: the role of avoidance behaviour.
    Vilches TN; Jaberi-Douraki M; Moghadas SM
    Epidemiol Infect; 2019 Jan; 147():e75. PubMed ID: 30869007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Public Health Measures in an Influenza Pandemic - the importance of surveillance.
    Nicoll A; ; Ciancio B; de la Hoz KF; Kreidl P; Needham H; Varela C; Vasconcelos P; Webber JT; Wurz A
    Euro Surveill; 2007 Nov; 12(11):E071101.4. PubMed ID: 17997909
    [No Abstract]   [Full Text] [Related]  

  • 30. Optimal control and sensitivity analysis of an influenza model with treatment and vaccination.
    Tchuenche JM; Khamis SA; Agusto FB; Mpeshe SC
    Acta Biotheor; 2011 Mar; 59(1):1-28. PubMed ID: 20140696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Various sides of influenza. Part II--epidemiology, influenza surveillance and prophylaxis].
    Machała MK; Brydak LB
    Pol Merkur Lekarski; 2006 Sep; 21(123):277-85. PubMed ID: 17163191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk groups and uptake of influenza and pneumococcal vaccine in Ireland.
    Mereckiene J; O'Donnell J; Collins C; Cotter S; Igoe D; O'Flanagan D
    Euro Surveill; 2007 Dec; 12(12):E13-4. PubMed ID: 18076858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic consequences to society of pandemic H1N1 influenza 2009 - preliminary results for Sweden.
    Brouwers L; Cakici B; Camitz M; Tegnell A; Boman M
    Euro Surveill; 2009 Sep; 14(37):. PubMed ID: 19761738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An innovative influenza vaccination policy: targeting last season's patients.
    Yamin D; Gavious A; Solnik E; Davidovitch N; Balicer RD; Galvani AP; Pliskin JS
    PLoS Comput Biol; 2014 May; 10(5):e1003643. PubMed ID: 24851863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive validation of an influenza spread model.
    Hyder A; Buckeridge DL; Leung B
    PLoS One; 2013; 8(6):e65459. PubMed ID: 23755236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seasonal Influenza Vaccination amongst Medical Students: A Social Network Analysis Based on a Cross-Sectional Study.
    Edge R; Heath J; Rowlingson B; Keegan TJ; Isba R
    PLoS One; 2015; 10(10):e0140085. PubMed ID: 26452223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Technical guidelines for seasonal influenza vaccination in China (2023-2024)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Oct; 44(10):1507-1530. PubMed ID: 37875437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics.
    Carrat F; Luong J; Lao H; Sallé AV; Lajaunie C; Wackernagel H
    BMC Med; 2006 Oct; 4():26. PubMed ID: 17059593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?
    Kissling E; Nunes B; Robertson C; Valenciano M; Reuss A; Larrauri A; Cohen JM; Oroszi B; Rizzo C; Machado A; Pitigoi D; Domegan L; Paradowska-Stankiewicz I; Buchholz U; Gherasim A; Daviaud I; Horváth JK; Bella A; Lupulescu E; O Donnell J; Korczyńska M; Moren A;
    Euro Surveill; 2016 Apr; 21(16):. PubMed ID: 27124420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.